Disability evaluation in patients with rare diseases in Spain: the importance of being in accord. BURQOL-RD Project.
Abstract
Most of rare diseases lead to a certain level of disability. In Spain, disabled persons receive long-time benefits, but only if they possess a disability evaluation that officially certifies the degree of their disability. Sometimes, the affected persons can experience disagreement with the obtained evaluation.
Our aim was to analyse the level of agreement among rare disease patients and caregivers in Spain with their official disability evaluation and their possible relationship with their health-related quality of life (HRQoL) and the general satisfaction with the national healthcare system (NHS).
Data were collected from patients and caregivers as a part of BURQOL-RD Project that measured the burden of ten rare diseases in Europe. HRQoL was evaluated by the generic instrument EQ-5D. Satisfaction with NHS was measured on a scale from 1 to 10.
Almost 30% of respondents did not agree with their disability evaluation. These persons expressed less satisfaction with NHS than those who were in accord with their evaluation (5.1 vs. 6.8; p<0.0001). Patients’ and caregivers’ HRQoL was also worse for the disagreement group, but did not reach a statistical significance.
Correctly evaluated degree of disability is fundamental and has many consequences for all affected parties. Disability evaluation rules should reflect the specificities of rare diseases.
Keywords
Full Text:
PDFReferences
WHO: Disabilities. http://www.who.int/topics/disabilities/en/. Accessed 10 September 2015.
European Platform for rehabilitation. The EU disability strategy. Analysis paper. http://www.epr.eu/images/EPR/documents/policy_documents/The%20EU%20Disability%20Strategy%20Analysis%20paper.pdf. Accessed 10 September 2015.
Eurordis. Rare Diseases: understanding this Public Health Priority. November 2005. http://www.eurordis.org/IMG/pdf/princeps_document-EN.pdf. Accessed 10 September 2015.
FEDER. Estudio sobre situación de necesidades sociosanitarias de las personas con enfermedades raras en España. Estudio ENSERio. Obra Social de Caja Madrid. October 2009.
Council of Europe: Assessing disability in Europe – Similarities and differences. Working Group on the assessment of person-related criteria for allowances and personal assistance for people with disabilities (P-RR-ECA). 2002. http://www.coe.int/t/e/social_cohesion/soc-sp/4744-2%20Assessing%20Disability%20in%20Europe%20%20E%2004%2002%20Reprint.pdf. Accessed 3 September 2015.
Sin-limite.net: El certificado de discapacidad en España. 2006. http://www.sin-limite.net/portal/content.asp?contentid=617. Accessed 10 September 2015.
Linertová R, Serrano-Aguilar P, Posada-de-la-Paz M, Hens-Pérez M, Kanavos P, Taruscio D, Schieppati A, Stefanov R, Péntek M, Delgado C, von der Schulenburg JM, Persson U, Chevreul K, Fattore G, Worbes-Cerezo M, Sefton M, López-Bastida J; BURQOL-RD Research Group. Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study. Health Policy. 2012 Nov;108(1):19-26.
Angelis A, Kanavos P, López-Bastida J, Linertová R, Nicod E, Serrano-Aguilar P; BURQOL-RD Research Network. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom. BMC Health Serv Res. 2015 Sep 28;15(1):428. doi: 10.1186/s12913-015-1061-3.
López-Bastida J, Linertová R, Oliva-Moreno J, Posada-de-la-Paz M, Serrano-Aguilar P. Social economic costs and health-related quality of life in patients with systemic sclerosis in Spain. Arthritis Care Res (Hoboken). 2014 Mar;66(3):473-80.
Serrano-Aguilar P, Linertová R, Posada-De-la-Paz M, López-Bastida J, González-Hernández N, Taruscio D, BURQOL-RD Research Network. Recruitment procedures for descriptive socio-economic studies in rare diseases. The BURQOL-RD project. Expert Opinion on Orphan Drugs. 2015; 3(7):759-765.
Chevreul K, Brigham KB, Gandré C, Mouthon L; BURQOL-RD Research Network. The economic burden and health-related quality of life associated with systemic sclerosis in France. Scand J Rheumatol. 2015 May;44(3):238-46.
Kodra Y, Cavazza M, Schieppati A, De Santis M, Armeni P, Arcieri R, Calizzani G, Fattore G, Manzoli L, Mantovani L, Taruscio D. The social burden and quality of life of patients with haemophilia in Italy. Blood Transfus. 2014 Apr;12 Suppl 3:s567-75.
Badia X, Roset M, Montserrat S, Herdman M, Segura A: The Spanish version of EuroQol: a description and its applications. European Quality of Life scale. Med Clin. 1999;112:79-85.
Dolan P. Modeling valuations for EuroQol health states. Med Care 1997. 35:1095-1108.
Hunter J, Rivero-Arias O, Angelov A, Kim E, Fotheringham I, Leal J. Epidemiology of fragile X syndrome: a systematic review and meta-analysis. Am J Med Genet A. 2014 Jul;164A(7):1648-58.
Mendell JR, Shilling C, Leslie ND, et al. Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol 2012;71:304–13.
Montserrat Moliner A, Waligóra J. The European union policy in the field of rare diseases. Public Health Genomics. 2013;16(6):268-77.
McGarvey, B. and Hart, C., 2009. An Investigation into the social support needs of families who experience rare disorders on the island of Ireland. Dublin: RehabCare.
Rajmil L, Perestelo-Pérez L, Herdman M. Quality of life and rare diseases. Adv Exp Med Biol. 2010;686:251-72.
Anderson M, Elliott EJ, Zurynski YA. Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support. Orphanet J Rare Dis. 2013 Feb 11;8:22. doi: 10.1186/1750-1172-8-22.
Eurordis Survey of the Delay in Diagnosis for 8 Rare Diseases in Europe ('EurordisCare 2') 2006. http://www.eurordis.org/IMG/pdf/Fact_Sheet_Eurordiscare2.pdf. Accessed 6 November 2015.
Kole A, Faurisson F. The Voice of 12,000 Patients: Experiences and expecttations of rare disease patients on diagnosis and care in Europe. Eurordis; 2009. http://www.eurordis.org/publication/voice-12000-patients. Accessed 6 November 2015.
Rahi JS, Manaras I, Tuomainen H, Hundt GL. Meeting the needs of parents around the time of diagnosis of disability among their children: evaluation of a novel program for information, support, and liaison by key workers. Pediatrics. 2004 Oct;114(4):e477-82.
Dellve L, Samuelsson L, Tallborn A, Fasth A, Hallberg LR. Stress and well-being among parents of children with rare diseases: a prospective intervention study. J Adv Nurs. 2006 Feb;53(4):392-402.
